Introduction
Heart failure (HF) is a major public health problem. It is estimated that the prevalence of HF is 1-2% in the general population and as high as 10% in patients over 70 years of age [1] . Rapid increase in the number of patients with HF is a consequence of both the aging of society and the development of interventional cardiology and electrotherapy. Currently, the most common causes of HF are ischemic heart disease and hypertension. HF is associated with very poor prognosis and 5-year survival rates are worse than for most cancers [2] .
The aim of this study was to present the clinical profile of patients hospitalized for heart failure in the cardiology department of a multi-specialty district hospital in Poland.
Material and methods
Medical records of 10,925 patients hospitalized at the Western Hospital in Grodzisk Mazowiecki, Poland in the first quarter of 2015 were analyzed retrospectively. Of this group, the authors selected medical records of 100 consecutive patients hospitalized in the cardiology department in whom HF was indicated in the hospital discharge summary as a primary diagnosis. Folia Cardiologica 2017, vol. 12, no. 4 www.journals.viamedica.pl/folia_cardiologica
Clinical characteristics of patients
Among the selected patients, the median age was 73 years. In this population, males accounted for 63% of the patients, were younger and had lower comorbidity burden compared with hospitalized women. Nearly one third of the patients were admitted in an urgent mode based on the decision by the Emergency Medical Service team; 64% of the patients reported the New York Heart Association (NYHA) class III or IV symptoms at admission. The most common concomitant disease was hypertension, which affected 64% of the patients. Supraventricular arrhythmias, i.e. atrial fibrillation or flutter, occurred in 38% of the patients, and 46% had coronary artery disease. The most common valvular heart defect was mitral regurgitation, which was almost 6 times more frequent than aortic stenosis (mild valvular heart defects in echocardiographic evaluation were disregarded). Mean levels of N-terminal B-type natriuretic propeptide (NT-proBNP) and sodium were 4819 ± 6968 pg/mL and 138 ± 4 mmol/L, accordingly. Most patients had impaired renal function, defined as glomerular filtration rate (GFR) less than 50 mL/min/1.73 m 2 , and 17% had stage 4/5 chronic renal disease. Thirty-one percent of the patients had left ventricular ejection fraction (LVEF) ≥ 50%. Forty--two percent of the patients had left ventricular systolic dysfunction of various degrees, of which 2/3 had an LVEF less than 40%. Twenty-eight percent of the patients did not undergo echocardiographic evaluation of LVEF during hospitalization (Table 1) .
Discussion
It is estimated that the number of patients with HF in Poland is 600-700 thousand and that every fifth person will develop HF at some point of his/her life [2] . Medical care for patients with HF both in outpatient setting and during frequent hospitalizations due to HF exacerbation, which are typical of the natural course of the disease, cause considerable social and financial burden.
Our analysis included patients hospitalized in the cardiology department of a multi-specialty district hospital, where there is also a department of internal diseases. The decision about the destination of the patient (a department of cardiology vs. department of internal diseases) is taken during his/her stay at the Hospital Emergency Department, usually after prior cardiac consultation. This allows for identification of patients who require specialist treatment ( Table 2 ).
The mean age of patients hospitalized due to HF in Poland is consistent with the age of patients participating in large registry trials in developed countries such as Japan (ATTEND) [3] , France (EFICA) [4] or USA (ADHERE [5] , OPTIMIZE-HF [6] ). • < 30
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• ≥ 50% 27% 15% 31% NYHA -New York Heart Association; PCI -percutaneous coronary intervention; CABG -coronary artery bypass grafting; AF -atrial fibrillation; AFL -atrial flutter; COPD -chronic obstructive pulmonary disease; ICD -implantable cardioverter-defibrillator; CRT -cardiac resynchronization therapy; TIA -transient ischemic attack; BMI -body mass index; NT-proBNP -N-terminal B-type natriuretic propeptide; Hb -hemoglobin; Na -sodium; GFR -glomerular filtration rate; LVEF -left ventricular ejection fraction Table 2 .
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As in most European registries, such as ESC-HF Pilot [7] , EHFS II [8] , IN-HF [9] , also in our study the majority of hospitalized patients (63%) were males. Women are traditionally less represented, not only in randomized clinical trials on HF but also in hospital registries. There is, however, one exception -available data indicate higher proportion of women requiring hospitalization due to HF only in the United States, which is contrary not only to data obtained in Europe but also in other regions of the world.
It is also worth noting that, as shown in the Western Hospital registry, women at the time of diagnosis of HF were older than men and were more likely to have heart failure with preserved ejection fraction (HFpEF).
The lower prevalence of coronary heart disease observed in our study (46% vs 50-57% in other registries) may be due to a slightly different questionnaire developed to describe a population in which coronary artery disease was diagnosed solely based on a history of myocardial infarction, prior coronary revascularization or coronary angiography. However, when taking into account the proportion of patients with HF and a history of myocardial infarction, the differences are much lower -24% vs. 22% in the French registry or 31% in the US registry.
The prevalence of hypertension at 58% is similar to data from all European registries. The exception is again American population, where hypertension is present in about 75% of people. This is obviously related to a higher prevalence of obesity in US society compared to Western Europe or Poland.
A similar pattern is observed regarding the prevalence of type 2 diabetes. Its frequency, due to the epidemic of obesity, is markedly higher in the US (40--44%) compared with the Polish population presented in our study (29%) or the French registry (27%). As showed by all registries, atrial fibrillation affects about 38-40% of patients hospitalized due to HF and is, along with hypertension, the major comorbid condition accompanying HFpEF.
It is also worth noting that the proportion of HFpEF patients hospitalized in recent years has gradually increased. Since many hospital records do not show LVEF values, we still do not have reliable epidemiological data on the actual HfrEF/HFpEF ratio. It seems, however, that this percentage can reach as much as 60-65% of hospitalized patients, which is also confirmed by the presented registry.
Data concerning the occurrence of comorbid conditions, such as chronic kidney disease (CKD) or chronic obstructive pulmonary disease (COPD), are also comparable between various HF registries. For example, the prevalence of CKD with GFR < 30 mL/min/1.73 m 2 is 17% in the presented registry vs 20% in global registries [12] . The prevalence of COPD (16%) is consistent with both OPTIMIZE-HF (15%) [6] and European EHFS II (19%) [8] .
Conclusions
New registry trials have been emerging over recent years. The data collected in these databases provide an excellent source of information both for the medical professionals and for healthcare system managers. Cardiovascular societies continuously update the guidelines for the diagnosis and treatment of HF -both considering the results of clinical trials, in which the patient population is selected and unrealistic due to strict criteria for inclusion and exclusion, and analyzing clinical practice based on registry data. The study presented above proves that the clinical profile of Polish patients is very similar to that of patients in developed countries. For a practitioner, this means that recommendations in the guidelines of the European Society of Cardiology can and should be directly implemented in the treatment of Polish patients.
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Streszczenie
Wstęp. Niewydolność serca (HF) stanowi poważny problem współczesnej medycyny. Choroba charakteryzuje się wysoką śmiertelnością, a rosnąca liczba chorych pociąga za sobą wysokie koszty ochrony zdrowia.
Materiał i metody. W niniejszej pracy oceniono profil kliniczny 100 pacjentów hospitalizowanych w pierwszym kwartale 2015 roku na oddziale kardiologicznym szpitala powiatowego.
Wyniki. Średni wiek chorych wynosił 73 lata (63% mężczyzn). Najczęstszymi chorobami towarzyszącymi były: nadciśnie-nie tętnicze (58%), choroba wieńcowa (46%), umiarkowana wada mitralna lub aortalna (34%), migotanie przedsionków (38%), cukrzyca (29%).
Wnioski. Dane z rejestrów są pomocne zarówno dla środowiska lekarskiego, jak i zarządzających służbą zdrowia.
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